share_log

Recursion Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

SEC ·  Aug 7 13:36
Summary by Moomoo AI
Christopher Gibson, an officer and director at Recursion Pharmaceuticals, Inc., is set to sell 30,000 Class A shares of the company on 08/07/2024, with an aggregate market value of $213,000. These shares were originally acquired on 09/01/2016 as founders shares, a form of compensation from the issuer. This planned sale follows a three-month period where a total of 200,000 shares were sold for gross proceeds of $1,618,500.
Christopher Gibson, an officer and director at Recursion Pharmaceuticals, Inc., is set to sell 30,000 Class A shares of the company on 08/07/2024, with an aggregate market value of $213,000. These shares were originally acquired on 09/01/2016 as founders shares, a form of compensation from the issuer. This planned sale follows a three-month period where a total of 200,000 shares were sold for gross proceeds of $1,618,500.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more